Stay updated with breaking news from Bio Techne. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
William Blair began coverage on shares of Bio-Techne (NASDAQ:TECH – Free Report) in a research report released on Monday morning, MarketBeat reports. The firm issued an outperform rating on the biotechnology company’s stock. William Blair also issued estimates for Bio-Techne’s Q1 2024 earnings at $0.40 EPS, Q2 2024 earnings at $0.40 EPS, Q3 2024 earnings […]
Itau Unibanco Holding S.A. boosted its position in shares of Bio-Techne Co. (NASDAQ:TECH – Free Report) by 322.0% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 6,621 shares of the biotechnology company’s stock after acquiring an additional 5,052 shares during the period. […]
Understanding the intrinsic value of Bio-Techne Corp (TECH) and its investment potential
Delving into the financial growth, competitive edges, and market outperformance of Bio-Techne Corp (TECH)
Bio-Techne Co. (NASDAQ:TECH – Get Free Report) shares traded down 2% during trading on Monday . The stock traded as low as $77.54 and last traded at $78.57. 184,823 shares traded hands during trading, a decline of 81% from the average session volume of 979,527 shares. The stock had previously closed at $80.16. Wall Street […]